Repurposing GLP-1 receptor agonists for alcohol use disorder: a systematic review and meta-analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Repurposing GLP-1 receptor agonists for alcohol use disorder: a systematic review and meta-analysis.
- Published In:
- Diabetology & metabolic syndrome, 18(1), 29 (2026)
- Authors:
- Nasrollahizadeh, Amir, Kheiri, Ghazaleh, Javankiani, Sepide, Kheiri, Sadra, Hamzavi, Seyedeh Fatemeh, Karimi, Mehdi, Amini-Salehi, Ehsan, Karimi, Mohammad Amin
- Database ID:
- RPEP-15777
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15777APA
Nasrollahizadeh, Amir; Kheiri, Ghazaleh; Javankiani, Sepide; Kheiri, Sadra; Hamzavi, Seyedeh Fatemeh; Karimi, Mehdi; Amini-Salehi, Ehsan; Karimi, Mohammad Amin. (2026). Repurposing GLP-1 receptor agonists for alcohol use disorder: a systematic review and meta-analysis.. Diabetology & metabolic syndrome, 18(1), 29. https://doi.org/10.1186/s13098-025-02006-x
MLA
Nasrollahizadeh, Amir, et al. "Repurposing GLP-1 receptor agonists for alcohol use disorder: a systematic review and meta-analysis.." Diabetology & metabolic syndrome, 2026. https://doi.org/10.1186/s13098-025-02006-x
RethinkPeptides
RethinkPeptides Research Database. "Repurposing GLP-1 receptor agonists for alcohol use disorder..." RPEP-15777. Retrieved from https://rethinkpeptides.com/research/nasrollahizadeh-2026-repurposing-glp1-receptor-agonists
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.